Key points are not available for this paper at this time.
Serum GSH may serve as a systemic biomarker of endoscopic disease activity in IBD, particularly CD. While less accurate than fecal calprotectin alone, systemic oxidative stress markers strongly enhance its diagnostic performance, suggesting complementary value for disease monitoring.
Holstein et al. (Thu,) studied this question.